CVS Caremark

SREE CHAGUTURU, MD, CHIEF MEDICAL OFFICER, CVS HEALTH, BECOMES CHAIR OF THE AMERICAN TELEMEDICINE ASSOCIATION BOARD OF DIRECTORS

Retrieved on: 
Friday, May 3, 2024
Nexus, Alpert Medical School, CVS, DNP, FAAN, Mass, Hospital, Policy, Health, PBM, Internal medicine, MD, Brown University, CVS Health, Patient safety, Telehealth, Medicine, CVS Caremark, American Telemedicine Association, Biology, Mass General Brigham, ATA, Massachusetts General Hospital, COVID-19

WASHINGTON, May 3, 2024 /PRNewswire/ -- The American Telemedicine Association (ATA) today announced that Sree Chaguturu, MD, has become Chair of the Board of Directors.

Key Points: 
  • WASHINGTON, May 3, 2024 /PRNewswire/ -- The American Telemedicine Association (ATA) today announced that Sree Chaguturu, MD, has become Chair of the Board of Directors.
  • Dr. Chaguturu is Executive Vice President and Chief Medical Officer, CVS Health®, where he leads the enterprise medical affairs organization spanning across all segments: Aetna®, CVS HealthSpire®, CVS Pharmacy®.
  • Dr. Chaguturu becomes ATA Chair of the Board beginning immediately, succeeding Kristi Henderson, DNP, FAAN, CEO, Confluent Health.
  • Before joining CVS Health, Sree was chief population health officer of Mass General Brigham, the largest health care system in Massachusetts.

SHARx Hires Andrew D. Crawford as President

Retrieved on: 
Wednesday, May 1, 2024
Professional Services, Health, Hospitals, Insurance, Health Insurance, Pharmaceutical, PBM, Pharmacy, Growth, CVS Caremark, Nursing

SHARx, one of the nation’s fastest-growing patient advocacy corporations, announced the hiring of Andrew D. Crawford as President.

Key Points: 
  • SHARx, one of the nation’s fastest-growing patient advocacy corporations, announced the hiring of Andrew D. Crawford as President.
  • Crawford previously served as the Chief Executive Officer of RxLogic, where he led the company through its start-up phases and into high-growth mode.
  • At SHARx he will report to CEO Corey Durbin and oversee the commercial operations of the firm as it continues on its high-growth trajectory.
  • “As SHARx has grown from the seed of an idea into one of the nation’s leading patient advocacy companies, the need for a President with Drew’s experience has become clear,” said CEO Corey Durbin.

Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to support Georgia Title 1 schools

Retrieved on: 
Thursday, April 11, 2024
Well, Blue Shield, Anthem, Spouse, Learning, Essay, Community health, Good Sports, Heart, School, Elevance Health, Partnership, Atlanta Hawks, Work, CVS Caremark, Student, Peach, Organization

ATLANTA, April 11, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR) and Anthem Blue Cross and Blue Shield of Georgia jointly announced today an initiative to reward State Health Benefit Plan (SHBP) members for engaging in healthy behaviors and support two Georgia Title 1 schools1 in the process. 

Key Points: 
  • Initiative made possible by community partners Sharecare, Anthem Blue Cross and Blue Shield – Georgia, CVS Caremark, Atlanta Hawks, and Good Sports
    ATLANTA, April 11, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ) and Anthem Blue Cross and Blue Shield of Georgia jointly announced today an initiative to reward State Health Benefit Plan (SHBP) members for engaging in healthy behaviors and support two Georgia Title 1 schools1 in the process.
  • To participate, SHBP members simply join the Jump Shot for Health steps challenge in the Sharecare app and select a school as the “team” to which they will allocate their daily steps count.
  • “By sponsoring the Jump Shot for Health program, Anthem furthers its mission of advancing physical activity and promoting healthy lifestyles for Georgia students and educators,” said Janalyn Kelly, state account vice president, Anthem Blue Cross Blue Shield - Georgia.
  • Administrators at Georgia Title 1 schools interested in learning more about Jump Shot for Health can visit the program’s information page for the latest information and updates.

Federal Court Rules CVS Acted With "Deliberate Indifference" When It Adopted Rx Program That Discriminates Against People Living With HIV, Says Consumer Watchdog

Retrieved on: 
Friday, April 19, 2024
CVS, Pharmacy, LLP, Supreme court, CVS Pharmacy, Senior counsel, District court, Pressure, Consumer Watchdog, Medicine, CVS Caremark, Order, Failure, Multimedia, HIV, Affordable Care Act, Lawyer, Pharmacist, Health insurance

The lawsuit alleges that the program cuts off access to knowledgeable pharmacists and other critical benefits and services essential for people living with HIV.

Key Points: 
  • The lawsuit alleges that the program cuts off access to knowledgeable pharmacists and other critical benefits and services essential for people living with HIV.
  • The four HIV-positive "John Doe" Plaintiffs in the case are represented by lawyers for the non-profit Consumer Watchdog and Whatley Kallas, LLP.
  • "… Plaintiffs sufficiently allege that Defendants implemented The Program by "utiliz[ing] its discretion" under its contracts with employers and 'offer[ing] financial inducements to plan sponsors.
  • Furthermore...CVS Caremark has an ongoing ability to alter plan terms and the prescription drug benefits provided thereunder to Class Members.

Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial

Retrieved on: 
Thursday, April 4, 2024
Element, Employment, CVS Caremark, CVS, Rite Aid, Accusative case, Federation, District court, Pharmacy, False Claims Act, CVS Health, Fraud, Caremark, Multimedia, Medicare, Government, Court, PBM, Pharmaceutical industry

PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.

Key Points: 
  • PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
  • The case is brought under the False Claims Act which allows private individuals to bring claims on behalf of the government to recover for fraud against the government.
  • In its summary judgment decision, the Court rejected the CVS Health defendants' attempt to have the claims dismissed without trial.
  • We are very pleased with the Court's ruling and look forward to presenting our case to a jury at trial," said Sorensen.

Digital Health Strategies Closes Series A Funding Round to Expand Its Share of Health™ Patient Loyalty Platform

Retrieved on: 
Monday, December 4, 2023
Software, General Health, Professional Services, Fintech, Data Management, Technology, Health Technology, Health Insurance, Data Analytics, Insurance, Finance, Health, Keck Hospital of USC, GS, Research, NYSE, Senior, Entrepreneurship, THC, Cystic fibrosis, Tenet Healthcare, Biotechnology, The Wall Street Journal, Optum, General Atlantic, Patient, Former, Providence Health & Services, Hackensack Meridian Health, Goldman Sachs, Heart, Digital, Social determinants of health, CVS Caremark, DHS, Cystic Fibrosis Foundation, Management, Citigroup

Digital Health Strategies, Inc. (DHS), a healthcare-exclusive, data and technology-enabled solutions company, today announced it has closed a Series A funding round to expand its Share of Health™ patient loyalty platform.

Key Points: 
  • Digital Health Strategies, Inc. (DHS), a healthcare-exclusive, data and technology-enabled solutions company, today announced it has closed a Series A funding round to expand its Share of Health™ patient loyalty platform.
  • The company’s clients include some of the largest health systems in the country including Geisinger, Hackensack Meridian Health and Providence Health.
  • With the support of the country's most respected healthcare leaders, DHS is poised to supercharge the next phase of the company’s growth.
  • “Cultivating patient loyalty is imperative as health systems have increasingly grown to own more of the continuum of care,” said Ben Texter, co-founder and co-CEO of DHS.

Meharry Medical College Launches Nation’s First School of Global Health

Retrieved on: 
Monday, November 13, 2023
Diabetes, Health, Other Health, Training, Other Education, Continuing, University, Practice Management, Managed Care, Education, General Health, Hospitals, Fitness & Nutrition, Nursing, JD, Social, Global health, Health equity, STEM, DHL, Meharry Medical College, Global Health, Congress, Trustee, MBA, Mental health, Medical college, The Kresge Foundation, Knowledge, School, CVS Health, HIV, Behavioural sciences, American Public Health Association, Doctor of Public Health, Public health, PEPFAR, CVS Caremark, Female, Public, Medicine, Student, MCP, Accreditation, HBCU, Together for Change, BSPH, Research, Policy, Hope, LLP, FACC, Morehouse School of Medicine, Faculty, COVID-19, MPH, Human, Management, Pharmaceutical industry, Doctor of Philosophy

Meharry Medical College is advancing its work to eliminate global health inequities by establishing the first School of Global Health in the United States.

Key Points: 
  • Meharry Medical College is advancing its work to eliminate global health inequities by establishing the first School of Global Health in the United States.
  • The School is an outgrowth of the Institute of Global Health Equity, which Meharry launched in February of 2023.
  • The Meharry Board of Trustees unanimously approved Meharry establishing the School of Global Health at a meeting in October.
  • "As a former president of Meharry Medical College, it brings me great joy to witness the launch of the School of Global Health, which will be a global health equity pioneer," said Dr. David Satcher, the 16th U.S.

Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023
Orphan drug, Research, CVS Caremark, Carcinoma, Dermatology, Express Scripts, Quarter, Prescription, KOL, Probability, Nevoid basal-cell carcinoma syndrome, NESS, Patient, IQVIA, Pharmaceutical industry, Video game, Optum, Galderma

In the third quarter of 2023, TWYNEO maintained a high recurring base of prescribers compared to the second quarter.

Key Points: 
  • In the third quarter of 2023, TWYNEO maintained a high recurring base of prescribers compared to the second quarter.
  • According to IQVIA data, there have been over 13,000 prescriptions of EPSOLAY written in the third quarter of 2023 and over 65,000 prescriptions written to date.
  • Financial Results for the Quarter Ended September 30, 2023
    Total revenue in the three months was $0.2 million, which primarily consisted of licensing revenues from Galderma.
  • General and administrative expenses for the third quarter of 2023 were $1.9 million compared to $1.8 million for the same period in 2022.

Zydus appoints Mr. Punit Patel as President and CEO to lead its business operations in North America

Retrieved on: 
Monday, October 16, 2023
MCPHS University, Cardinal Health, CVS Health, Allied health professions, Zydus Lifesciences, Therapy, CVS Caremark, Doctor of Pharmacy, UnitedHealth Group, Health, Growth, Red Oak, Oklahoma, Red oak, Pharmaceutical industry, Pharmacy

AHMEDABAD, India, Oct. 16, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas.

Key Points: 
  • AHMEDABAD, India, Oct. 16, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas.
  • He will be responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics.
  • Prior to his joining Zydus, Mr. Punit Patel was the President of Red Oak Sourcing, helming a multi-billion-dollar generic portfolio.
  • "We look forward to Punit joining our organisation," said Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., "As a seasoned and successful business leader, Punit brings rich and varied experience in healthcare and pharmaceuticals to lead Zydus into the future.

ZETA LIVE 2023 Achieves Record Attendance with Over 12,000 Viewers, Growing 50% Year-Over-Year

Retrieved on: 
Wednesday, October 4, 2023
Business, Artificial Intelligence, Software, Internet, Professional Services, Data Management, Social Media, Technology, Search Engine Optimization, Search Engine Marketing, Digital Marketing, Data Analytics, Publishing, Public Relations, Investor Relations, Marketing, Advertising, Content Marketing, Communications, Apps, Applications, Cloud, Columbia University, Houseplant, World cup, EVP, Intelligence, Multimedia, CMO, PepsiCo, CCO, Zeta Global, P. V. Rajamannar, Creativity, CVS Caremark, Mastercard, Physics, David A. Steinberg, NYSE, Communications officer, ZETA, Management, Pepsi, Nationwide

Zeta Global (NYSE: ZETA), the AI-Powered Marketing Cloud, today announced that its third annual conference, ZETA LIVE 2023, achieved record attendance with over 12,000 global viewers in-person and streaming, growing 50% year-over-year ( with 2022’s viewers at approximately 8,000 ).

Key Points: 
  • Zeta Global (NYSE: ZETA), the AI-Powered Marketing Cloud, today announced that its third annual conference, ZETA LIVE 2023, achieved record attendance with over 12,000 global viewers in-person and streaming, growing 50% year-over-year ( with 2022’s viewers at approximately 8,000 ).
  • View the full release here: https://www.businesswire.com/news/home/20231004840391/en/
    NEW YORK, NEW YORK - SEPTEMBER 28: David A. Steinberg, Co-founder, Chairman, and CEO of Zeta Global with Seth Rogen and Evan Goldberg for the keynote "From Hollywood to Houseplant " during Zeta Live 2023 in NYC.
  • The annual conference is a collaborative consortium of global business leaders and creators and was held at The New York Times Center on September 28, 2023.
  • ZETA LIVE was a collaborative consortium of global marketing leaders, business visionaries, Zeta customers, and partners.